OPIANT PHARMACEUTICALS, INC. Annual Interest Expense in USD from 2012 to 2021

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Opiant Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from 2012 to 2021.
  • Opiant Pharmaceuticals, Inc. Interest Expense for the quarter ending September 30, 2022 was $391K, a 28.6% decline year-over-year.
  • Opiant Pharmaceuticals, Inc. Interest Expense for the twelve months ending September 30, 2022 was $1.72M, a 2.37% decline year-over-year.
  • Opiant Pharmaceuticals, Inc. annual Interest Expense for 2021 was $2.13M, a 1525% increase from 2020.
  • Opiant Pharmaceuticals, Inc. annual Interest Expense for 2020 was $131K.
  • Opiant Pharmaceuticals, Inc. annual Interest Expense for 2019 was $0.000.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $2.13M +$2M +1525% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-15
2020 $131K +$131K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 $0 Jan 1, 2019 Dec 31, 2019 10-K 2021-03-04
2015 $28.2K -$132K -82.4% Aug 1, 2014 Jul 31, 2015 10-K 2015-10-26
2014 $160K -$393K -71% Aug 1, 2013 Jul 31, 2014 10-K 2015-10-26
2013 $553K +$492K +801% Aug 1, 2012 Jul 31, 2013 10-K 2014-10-27
2012 $61.4K Aug 1, 2011 Jul 31, 2012 10-K 2013-10-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.